8 inhalants were measured. Epicutaneous SPTs were performed to 16 foods and 38 inhalant allergens. Patch testing to foods was also performed. IgE-mediated allergy was diagnosed if either serum-specific IgE or skinprick test results were positive, whereas non-IgE-mediated allergy was diagnosed if a positive patch test result was found. A streptavidin-based immunoassay was performed to determine the presence of cross-reactive carbohydrate determinants and Helicobacter pylori.
REVIEWER COMMENTS. The treatment of patients with eosinophilic esophagitis is challenging. The authors found that almost half of the patients were identified to have sensitization to a previously undiagnosed food allergen. Although the clinical significance of the serum-specific IgE might be argued, elimination diets for most patients with eosinophilic esophagitis leads to improvement. This study provides insight into another diagnostic modality, frequently used in the diagnosis of other allergic conditions, that might aid clinicians in the diagnosis and treatment of patients with eosinophilic esophagitis. However, more correlation with response to elimination of specific foods is needed. METHODS. EoE was defined as Ն15 eosinophils per highpowered field, whereas GERD biopsies had Ͻ15 eosinophils per high-powered field. Retrospective chart reviews were performed to assess clinical symptoms, and the presence of subepithelial fibrosis was assessed with esophageal biopsy specimens.
RESULTS. Subepithelial fibrosis was observed in 24 (89%) children with EoE and in 9 (38%) children with GERD (P Ͻ .0001). Fibrosis in EoE was not associated with lymphoid tissue and was less likely to occur in younger children (1.84 vs 7.02 years; P ϭ .02).
CONCLUSIONS. Subepithelial fibrosis was a common finding in children with EoE; it occurred in 89% of the children. Fibrosis was more likely to occur in older children and children with longer symptom duration.
REVIEWER COMMENTS. The finding of subepithelial fibrosis in children with EoE has long-term implications. If EoE pathophysiology has any similarity to asthma (which this article suggests), then early recognition and treatment to prevent fibrosis and remodeling of the esophagus are crucial. Esophageal remodeling might explain why some children with EoE have persistent symptoms despite reduction in eosinophils and why this disease is rarely short-lived.
characteristics of FD in children with eosinophilic gastrointestinal diseases (EGIDs).
STUDY POPULATION. The study included children previously evaluated in the multidisciplinary EGID program at Children's Hospital National Jewish Health (Aurora, CO) between January and December 2008.
METHODS. Retrospective analysis of medical records (N ϭ 200) assessed patients for EGID and FD (determined by feeding therapists using a feeding assessment that addressed symptoms, observation of functional skills, learned behaviors, mealtime dynamics with caregivers, and developmental skills).
RESULTS. Thirty-three (16.5%) patients (age range: 14 -113 months) were identified as having both EGID and FD. Food sensitivity was noted in 88% of the patients, and 52% of them had clinical evidence of other allergic disease. Twenty-five of the 33 patients (76%) had eosinophilic esophagitis, defined by Ն15 eosinophils per high-powered field. Learned maladaptive feeding behaviors were the predominant form of FD and were noted in 93.9% of the children; gagging or vomiting was seen in 84.8% of them. Twenty-one percent were diagnosed with failure to thrive, and nearly 70% required individual or group feeding therapy.
CONCLUSIONS. Feeding difficulties are prevalent in children with EGIDs and might persist even after eosinophilic inflammation is treated.
REVIEWER COMMENTS. This study highlights the importance of assessing for FD in children with EGIDs and vice versa, because appropriate management of both disease states might enhance outcomes. The authors were able to examine the records of a relatively large number of patients. Potential limitations of the study were its retrospective design, lack of a universally accepted feedingassessment protocol, and possible referral bias. PURPOSE OF THE STUDY. Some patients with eosinophilic esophagitis (EoE) demonstrate an increased number of eosinophils in gastric mucosa. These researchers sought to assess clinical and therapeutic differences in children with EoE and either no gastric eosinophils (EE-N) or an increased number of gastric eosinophils (EE-A).
STUDY POPULATION. Children aged 1 to 18 years who had had an esophagogastroduodenoscopy (EGD) over an 8-year period (1999 -2007) were assessed. The study was conducted at a children's hospital in Indianapolis, Indiana.
METHODS. A retrospective chart review was performed to identify children with EE-A, defined as EoE with Ն10 eosinophils per high-powered field in a gastric biopsy. Clinical characteristics and response to swallowed fluticasone between children with EE-A and children with EE-N were compared by using 2-sample t and 2 tests.
RESULTS.
A total of 356 children with EoE were identified: 41(12%) met criteria for EE-A. When compared to a randomly selected group of 50 children with EE-N, there was no difference regarding gender, age, presenting symptoms, atopy history, or esophageal histology. Both groups had similar responses to swallowed fluticasone (significant reductions in the number of esophageal eosinophils). In 11 children with EE-A treated with swallowed fluticasone, 9 (82%) had a reduction in the number of gastric eosinophils (to Ͻ5 eosinophils per high-powered field). No differences were observed between responders and nonresponders.
CONCLUSIONS. Twelve percent of the children with EoE had an increased number of gastric eosinophils; however, the presence of increased numbers of gastric eosinophils does not portend a worse clinical presentation or result in a reduced response to swallowed fluticasone.
REVIEWER COMMENTS. Just when we thought we were starting to understand EoE, gastroenterologists are now identifying children with clinical symptoms and an increased number of eosinophils in areas distal to the gastroesophageal junction. Although the authors admitted that they did not have a study group of patients with only eosinophilic gastritis, the lack of differences between EE-N and EE-A was reassuring. This study's results offer another twist in the continuing story of eosinophilic gastrointestinal disorders.
